Ferroptosis vulnerability in MYCN-driven neuroblastomas
- PMID: 35908258
- PMCID: PMC9339235
- DOI: 10.1002/ctm2.963
Ferroptosis vulnerability in MYCN-driven neuroblastomas
Conflict of interest statement
Boyi Gan is an inventor of patent applications involving targeting ferroptosis in cancer therapy. Shayani Dasgupta has no conflicts of interest to declare.
Figures
Comment on
-
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis.Nat Cancer. 2022 Apr;3(4):471-485. doi: 10.1038/s43018-022-00355-4. Epub 2022 Apr 28. Nat Cancer. 2022. PMID: 35484422 Free PMC article.
References
-
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646‐674. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical